[go: up one dir, main page]

(Q73775133)

English

Circulating antiganglioside antibodies are not associated with the development of progressive disease or cerebral atrophy in patients with multiple sclerosis

scientific article published on 01 May 2000

In more languages
default for all languages
No label defined

No description defined

Statements

Circulating antiganglioside antibodies are not associated with the development of progressive disease or cerebral atrophy in patients with multiple sclerosis (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit